Evidence map›Paper›PMID 27930303›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

Transcription factor Zeb2 regulates commitment to plasmacytoid dendritic cell and monocyte fate.

Xiaodi Wu, Carlos G Briseño, Gary E Grajales-Reyes, Malay Haldar, Arifumi Iwata, Nicole M Kretzer, Wumesh Kc, Roxane Tussiwand, Yujiro Higashi, Theresa L Murphy and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 89 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. C/EBPα activatesScience immunology · 2025
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. EvaluatingFrontiers in immunology · 2024
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Xiaodi WuDepartment of Pathology and Immunology, School of Medicine, Washington University, St. Louis, MO 63110.
Carlos G BriseñoDepartment of Pathology and Immunology, School of Medicine, Washington University, St. Louis, MO 63110.
Gary E Grajales-ReyesDepartment of Pathology and Immunology, School of Medicine, Washington University, St. Louis, MO 63110.
Malay HaldarDepartment of Pathology and Immunology, School of Medicine, Washington University, St. Louis, MO 63110.
Arifumi IwataDepartment of Pathology and Immunology, School of Medicine, Washington University, St. Louis, MO 63110.
Nicole M KretzerDepartment of Pathology and Immunology, School of Medicine, Washington University, St. Louis, MO 63110.
Wumesh KcDepartment of Pathology and Immunology, School of Medicine, Washington University, St. Louis, MO 63110.
Roxane TussiwandDepartment of Pathology and Immunology, School of Medicine, Washington University, St. Louis, MO 63110.
Yujiro HigashiDepartment of Perinatology, Institute for Developmental Research, Aichi Human Service Center, Kasugai, Aichi 480-0392, Japan.
Theresa L MurphyDepartment of Pathology and Immunology, School of Medicine, Washington University, St. Louis, MO 63110.
Kenneth M MurphyDepartment of Pathology and Immunology, School of Medicine, Washington University, St. Louis, MO 63110; kmurphy@wustl.edu.
Washington University in St. Louis · USAichi Human Service Center · JPHoward Hughes Medical Institute · US

Funding

Washington University Center for Cellular ImagingP30CA091842 · NCI · WASHINGTON UNIVERSITY · PI TIMOTHY J. EBERLEIN · 2001 to 2026
$128.0M
Washington University Institute of Clinical and Translational SciencesUL1TR000448 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$41.4M
METABOLIC CONTROL OF TISSUE SPECIFIC MACROPHAGE DIFFERENTIATIONK08AI106953 · NIAID · WASHINGTON UNIVERSITY · PI HALDAR, MALAY · 2013 to 2017
$857k
Deciphering CD8 Dendritic Cell Development for the Improvement of VaccineF31CA189491 · NCI · WASHINGTON UNIVERSITY · PI GRAJALES-REYES, GARY E. · 2014 to 2016
$89k
Howard Hughes Medical InstituteNCATS NIH HHS UL1 TR000448NCI NIH HHS F31 CA189491NCI NIH HHS P30 CA091842NIAID NIH HHS K08 AI106953
6 · The paper itself

Abstract

Dendritic cells (DCs) and monocytes develop from a series of bone-marrow-resident progenitors in which lineage potential is regulated by distinct transcription factors. Zeb2 is an E-box-binding protein associated with epithelial-mesenchymal transition and is widely expressed among hematopoietic lineages. Previously, we observed that Zeb2 expression is differentially regulated in progenitors committed to classical DC (cDC) subsets in vivo. Using systems for inducible gene deletion, we uncover a requirement for Zeb2 in the development of Ly-6C

Indexed as

Gene Expression RegulationAnimalsBone MarrowCD8-Positive T-LymphocytesCell LineageCytoplasmDendritic CellsFemaleFlow CytometryGene DeletionGene Expression ProfilingInflammationIntegrasesMaleMiceMonocytesCre recombinaseIntegrasesZEB2 protein, mouseZinc Finger E-box Binding Homeobox 2monocyteplasmacytoid dendritic celltranscription factor

Identifiers

PMID27930303
PMCPMC5187668
OpenAlexW2560238409

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.